军医进修学院学报2012，Vol.33Issue(6)：591-593,3.
贝那普利联合乐卡地平治疗轻中度高血压的近期疗效和安全性
Short-term therapeutic effect and safety of combined benazepril and lercanidipine for mildmoderate hypertension
钟震宇 1陈光辉 1杨慧娟 2安伟帅 1刘峻松1
作者信息
- 1. 解放军总医院,心血管内科,北京,100853
- 2. 解放军61001部队,门诊部,北京,100094
- 折叠
摘要
Abstract
Objective To observe the short-term therapeutic effect and safety of combined benazepril and lercanidipine for mild-moderate hypertension. Methods One hundred and one patients with mild-moderate hypertension were randomly divided into group A and group B. Four weeks after patients in group A were treated with combined benazepril(10mg/d) and lercanidipine(10mg/d) and those in group B were treated with benazepril(10mg/d) alone, benazepril was increased to 20mg/d for those with their DBP at sitting ≥ 90mmHg for 8 weeks. Then, their blood pressure reduction, curative effect and adverse reaction were assessed 1, 4 and 8 weeks after treatment with combined benazepril and lercanidipine. Results The DBP in two groups at sitting was lower after 1, 4 and 8 weeks of treatment with combined benazepril and lercanidipine than before treatment. The systolic and diastolic pressure at sitting was (133.72 ± 11.87)mmHg and (80.11 ± 8.77)mmHg respectively in group A, and (142.04 ± 12.34)mmHg and (87.56 ± 9.88) mmHg respectively in group B(P<0.05), with a total effective rate of 89.1% in group A and 67.0% in group B after 8 weeks of treatment(P<0.05). No significant difference was observed in adverse reaction between the two groups. Conclusion Combined benazepril and lercanidipine can decrease the blood pressure and increase the therapeutic effect for hypertension with no significant adverse reactions.关键词
贝那普利/乐卡地平/高血压Key words
benazepril/ lercanidipine/ hypertension分类
医药卫生引用本文复制引用
钟震宇,陈光辉,杨慧娟,安伟帅,刘峻松..贝那普利联合乐卡地平治疗轻中度高血压的近期疗效和安全性[J].军医进修学院学报,2012,33(6):591-593,3.
